Literature DB >> 16222300

Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells.

Takeshi Fujiwara1, Madhavi Bandi, Masayuki Nitta, Elena V Ivanova, Roderick T Bronson, David Pellman.   

Abstract

A long-standing hypothesis on tumorigenesis is that cell division failure, generating genetically unstable tetraploid cells, facilitates the development of aneuploid malignancies. Here we test this idea by transiently blocking cytokinesis in p53-null (p53-/-) mouse mammary epithelial cells (MMECs), enabling the isolation of diploid and tetraploid cultures. The tetraploid cells had an increase in the frequency of whole-chromosome mis-segregation and chromosomal rearrangements. Only the tetraploid cells were transformed in vitro after exposure to a carcinogen. Furthermore, in the absence of carcinogen, only the tetraploid cells gave rise to malignant mammary epithelial cancers when transplanted subcutaneously into nude mice. These tumours all contained numerous non-reciprocal translocations and an 8-30-fold amplification of a chromosomal region containing a cluster of matrix metalloproteinase (MMP) genes. MMP overexpression is linked to mammary tumours in humans and animal models. Thus, tetraploidy enhances the frequency of chromosomal alterations and promotes tumour development in p53-/- MMECs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16222300     DOI: 10.1038/nature04217

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  477 in total

1.  Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells.

Authors:  Patrizia Vinciguerra; Susana A Godinho; Kalindi Parmar; David Pellman; Alan D D'Andrea
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest.

Authors:  Tiffany A Coon; Jennifer R Glasser; Rama K Mallampalli; Bill B Chen
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

3.  Replication-compromised cells require the mitotic checkpoint to prevent tetraploidization.

Authors:  Zilai Zhang; Sumit Arora; Yanjiao Zhou; Athena Cherry; Teresa S-F Wang
Journal:  Chromosoma       Date:  2010-09-09       Impact factor: 4.316

Review 4.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Persistent telomere damage induces bypass of mitosis and tetraploidy.

Authors:  Teresa Davoli; Eros Lazzerini Denchi; Titia de Lange
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

6.  Cre recombinase induces DNA damage and tetraploidy in the absence of loxP sites.

Authors:  Vaibhao C Janbandhu; Daniel Moik; Reinhard Fässler
Journal:  Cell Cycle       Date:  2013-11-26       Impact factor: 4.534

7.  Induction of endocycles represses apoptosis independently of differentiation and predisposes cells to genome instability.

Authors:  Christiane Hassel; Bingqing Zhang; Michael Dixon; Brian R Calvi
Journal:  Development       Date:  2013-11-27       Impact factor: 6.868

8.  Integrins promote cytokinesis through the RSK signaling axis.

Authors:  Shomita S Mathew; Bethsaida Nieves; Sharon Sequeira; Savitha Sambandamoorthy; Kevin Pumiglia; Melinda Larsen; Susan E Laflamme
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

9.  Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpoints.

Authors:  Stephan C Jahn; Patrick E Corsino; Bradley J Davis; Mary E Law; Peter Nørgaard; Brian K Law
Journal:  J Cell Sci       Date:  2013-01-15       Impact factor: 5.285

10.  Immunosurveillance against tetraploidization-induced colon tumorigenesis.

Authors:  Alice Boilève; Laura Senovilla; Ilio Vitale; Delphine Lissa; Isabelle Martins; Didier Métivier; Stieneke van den Brink; Hans Clevers; Lorenzo Galluzzi; Maria Castedo; Guido Kroemer
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.